Showing results (351-360 of 887) with videos related to

Sort By:
Pageof 89
Diabetes, Obesity & Metabolism|December 15, 2021
The effect of empagliflozin on the total burden of cardiovascular and hospitalization events in the Asian and non-Asian populations of the EMPA-REG OUTCOME trial of patients with type 2 diabetes and cardiovascular diseaseKohei Kaku, Christoph Wanner, Stefan D Anker, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 15, 2011
Predicting mortality in incident dialysis patients: an analysis of the United Kingdom Renal RegistryMartin Wagner, David Ansell, David M Kent, et al.
Atherosclerosis|October 24, 2007
Transmission of oxLDL-derived lipid peroxide radicals into membranes of vascular cells is the main inducer of oxLDL-mediated oxidative stressThomas E Hansen-Hagge, Elke Baumeister, Tanja Bauer, et al.
Journal of Diabetes and Its Complications|October 18, 2023
Shifts in KDIGO CKD risk groups with empagliflozin: Kidney-protection from SGLT2 inhibition across the spectrum of riskRobert Weingold, Bernard Zinman, Michaela Mattheus, et al.
Clinical Kidney Journal|December 21, 2016
Morbidity, mortality and quality of life in the ageing haemodialysis population: results from the ELDERLY studyJoerg Seckinger, Wilfried Dschietzig, Gerd Leimenstoll, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 8, 2011
Vitamin D status and mortality in chronic kidney diseaseStefan Pilz, Andreas Tomaschitz, Claudia Friedl, et al.
Artificial Organs|April 23, 2015
Pharmacokinetics of Certoparin During In Vitro and In Vivo DialysisDetlef H Krieter, Susanne Fink, Oliver Dorsch, et al.
Nephron|August 22, 2021
Comparison of Static and Dynamic Baseline Creatinine Surrogates for Defining Acute Kidney InjuryDavid G Warnock, Javier A Neyra, Etienne Macedo, et al.
Diabetes, Obesity & Metabolism|September 24, 2021
Empagliflozin and uric acid metabolism in diabetes: A post hoc analysis of the EMPA-REG OUTCOME trialJoão Pedro Ferreira, Silvio E Inzucchi, Michaela Mattheus, et al.
Kidney International|October 10, 2002
Inflammation and outcome in end-stage renal failure: does female gender constitute a survival advantage?Peter Stenvinkel, Christoph Wanner, Thomas Metzger, et al.
Pageof 89